跳至主要内容
临床试验/NCT03563638
NCT03563638已完成不适用

Maternal Serum Pentraxin 3 in Early Pregnancy to Predict Gestational Diabetes Mellitus

Shanghai First Maternity and Infant Hospital0 个研究点目标入组 824 人开始时间: 2015年10月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
824
主要终点
Serum PTX3 levels in early pregnancy

研究概览

简要总结

To investigate the association of maternal serum concentrations of pentraxin 3 in early pregnancy with gestational diabetes mellitus and to explore its potential value in the prediction of GDM.

详细描述

We recruited all pregnant women for the first checkup in our hospital . Maternal fasting serum PTX3 levels, fasting plasma glucose and fasting insulin and other factors were measured. Oral glucose tolerance test (OGTT) was performed at 24-28 weeks in all participants. According to the occurrence of GDM, subjects were divided into two groups: GDM group and normal glucose tolerance (NGT) group.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Retrospective

入排标准

年龄范围
27 Years 至 33 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Women with maternal age ≥ 18 years, singleton pregnancy, primipara, no smoking, confirmed gestation≤20 weeks and spontaneous conception were invited to participate in the study.

排除标准

  • Women were excluded if they had multiple pregnancy, pre-gestational diabetes mellitus (PGDM), hypertensive disorders, preterm delivery, cardiovascular disease, immunological disease, glucocorticoid therapy, or other severe illness. In addition, women who were suffering from fetal abnormalities including chromosomally abnormal fetuses and/or structural defects and fetal growth restriction occurred during pregnancy were also excluded from the study.

结局指标

主要结局

Serum PTX3 levels in early pregnancy

时间窗: 2015.10.01-2015.11.31

Serum PTX3 levels in early pregnancy

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

相似试验